Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MK-8353
MK-8353
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Endpoints
Sat, 02/24/18 - 10:21 am
Merck
melanoma
clinical trials
MK-8353